Recent Contracts
Active
Drugs and Pharmaceutical
CN4171505—Procurement of Imported Plasma and Recombinant Products (IPRP) – Hemlibra (emicizumab)$317.7M
30 June 2025 - 29 June 2028
Expired
Drugs and Pharmaceutical
CN3727716—Supply of Hemlibra$353.2M
31 Oct 2020 - 29 June 2025
Live opportunities
Open tenders and contracts coming up for retender in this supplier's categories.
~10mo until expiry
Agency + Category
Drugs and Pharmaceutical
~10mo until expiry
Category + Value
Drugs and Pharmaceutical
~10mo until expiry
Category + Value
Drugs and Pharmaceutical
Unlock 7 more matches + your Opportunity Radar
Starter matches renewals and live tenders to your company, then emails you the best of them every Monday.
Sign up to subscribe →Peer Benchmarking
See how ROCHE PRODUCTS PTY LTD ranks against similar companies in their category and size band.
Unlock benchmarking →Financial Year Breakdown
FY25
$317.7M(1 contracts)
FY21
$353.2M(1 contracts)
Company Details
- Name
- ROCHE PRODUCTS PTY LTD
- Also known as
- Roche Foundation Medicine
- Entity Type
- Australian Private Company
- ABN
- 70 000 132 865
- ACN
- 000 132 865
- Status
- Registered
- Registered
- 3 June 1954
- Town/City
- Sydney
- Postcode
- 2000
- State/Territory
- NSW
- Country
- Australia